Locksley Resources (ASX: LKY) hits 99.5% purity antimony trioxide milestone, opening U.S. defense supply chain pathway
How Accenture is using Google Cloud and Wiz to close security blind spots in modern multi-cloud infrastructure
Read More 5 minute read Healthcare Industry News Is Fulgent Genetics rebuilding itself as a pathology-first diagnostics platform after losing a major customer? Fulgent Genetics targets $350M 2026 revenue as pathology expansion reshapes its customer mix. Read how the strategy could stabilise growth. byPallavi MadhirajuMarch 1, 2026